Physician profile
Erin L Wright
NPI 1477746121
$2,952.40
in general payments reported to CMS, 2019-2025
18 companies · $1,025 in 2025
The $1,025 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $127 · 2022: $433 · 2023: $776 · 2024: $482 · 2025: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,282.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $469.46 | 2022-2025 | Linq II, Inceptiv |
| Amgen INC. | $424.42 | 2023-2025 | Tavneos, Otezla, Repatha |
| Lilly USA, LLC | $311.79 | 2022-2025 | Mounjaro, Jardiance |
| Neurocrine Biosciences, INC. | $241.53 | 2022-2023 | Ingrezza |
| Abbvie INC. | $231.65 | 2019-2025 | |
| Si-Bone, INC. | $169.88 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $131.40 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $128.36 | 2022-2025 | Airsupra |
| Teva Pharmaceuticals USA, INC. | $127.02 | 2020 | |
| Stryker Corporation | $121.13 | 2025 | Flowtriever |
| Merck Sharp & Dohme LLC | $110.45 | 2023-2024 | Capvaxive, Vaxneuvance |
| Idorsia Pharmaceuticals US INC | $88.05 | 2023 | Quviviq |
| Biosense Webster, INC. | $85.53 | 2025 | Carto 3 |
| Inspire Medical Systems, INC. | $85.07 | 2024-2025 | Inspire |
| Procept Biorobotics Corporation | $69.04 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $67.94 | 2025 | Recorlev |
| E.R. Squibb & Sons, L.L.C. | $67.32 | 2022 | |
| Sk Life Science, INC. | $22.36 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.